[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

IL133788A0 - Tricyclic vasopressin agonists - Google Patents

Tricyclic vasopressin agonists

Info

Publication number
IL133788A0
IL133788A0 IL13378898A IL13378898A IL133788A0 IL 133788 A0 IL133788 A0 IL 133788A0 IL 13378898 A IL13378898 A IL 13378898A IL 13378898 A IL13378898 A IL 13378898A IL 133788 A0 IL133788 A0 IL 133788A0
Authority
IL
Israel
Prior art keywords
vasopressin agonists
tricyclic
tricyclic vasopressin
agonists
vasopressin
Prior art date
Application number
IL13378898A
Other languages
English (en)
Original Assignee
American Home Prod
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by American Home Prod filed Critical American Home Prod
Publication of IL133788A0 publication Critical patent/IL133788A0/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/10—Drugs for disorders of the endocrine system of the posterior pituitary hormones, e.g. oxytocin, ADH
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/04—Antihaemorrhagics; Procoagulants; Haemostatic agents; Antifibrinolytic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/12—Antidiuretics, e.g. drugs for diabetes insipidus

Landscapes

  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Health & Medical Sciences (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Endocrinology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
IL13378898A 1997-07-30 1998-07-24 Tricyclic vasopressin agonists IL133788A0 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US90336997A 1997-07-30 1997-07-30
PCT/US1998/015495 WO1999006409A1 (fr) 1997-07-30 1998-07-24 Agonistes tricycliques de la vasopressine

Publications (1)

Publication Number Publication Date
IL133788A0 true IL133788A0 (en) 2001-04-30

Family

ID=25417392

Family Applications (1)

Application Number Title Priority Date Filing Date
IL13378898A IL133788A0 (en) 1997-07-30 1998-07-24 Tricyclic vasopressin agonists

Country Status (22)

Country Link
EP (1) EP1000062B1 (fr)
JP (1) JP4338305B2 (fr)
KR (1) KR100580805B1 (fr)
CN (1) CN1183134C (fr)
AR (1) AR016557A1 (fr)
AT (1) ATE277050T1 (fr)
AU (1) AU756959B2 (fr)
BR (1) BR9811585A (fr)
CA (1) CA2297406C (fr)
DE (1) DE69826487T2 (fr)
DK (1) DK1000062T3 (fr)
ES (1) ES2229525T3 (fr)
HU (1) HUP0002480A3 (fr)
IL (1) IL133788A0 (fr)
NO (1) NO315273B1 (fr)
NZ (1) NZ502449A (fr)
PT (1) PT1000062E (fr)
RU (1) RU2213094C2 (fr)
SI (1) SI1000062T1 (fr)
TW (1) TW502035B (fr)
WO (1) WO1999006409A1 (fr)
ZA (1) ZA986784B (fr)

Families Citing this family (31)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7138393B2 (en) * 1998-07-24 2006-11-21 Wyeth Biologically active vasopressin agonist metabolites
DK1147115T5 (da) * 1999-01-19 2008-12-08 Ortho Mcneil Pharm Inc Tricycliske benzodiazepiner som vasopressinreceptorantagonister
MXPA02003191A (es) * 1999-09-27 2002-09-30 American Cyanamid Co Formulacion agonista de vasopresina y proceso para elaborar la misma.
US6831079B1 (en) * 1999-09-27 2004-12-14 American Cyanamid Company Vasopressin agonist formulation and process
GB0000079D0 (en) 2000-01-05 2000-02-23 Ferring Bv Novel antidiuretic agents
GB0015601D0 (en) * 2000-06-26 2000-08-16 Ferring Bv Novel antidiuretic agents
US7022699B2 (en) 2001-04-12 2006-04-04 Wyeth Cyclohexenyl phenyl diazepines vasopressin and oxytocin receptor modulators
US6900200B2 (en) 2001-04-12 2005-05-31 Wyeth Tricyclic hydroxy carboxamides and derivatives thereof tocolytic oxytocin receptor antagonists
US7202239B2 (en) 2001-04-12 2007-04-10 Wyeth Cyclohexylphenyl carboxamides tocolytic oxytocin receptor antagonists
US7109193B2 (en) 2001-04-12 2006-09-19 Wyeth Tricyclic diazepines tocolytic oxytocin receptor antagonists
US7064120B2 (en) 2001-04-12 2006-06-20 Wyeth Tricyclic pyridyl carboxamides and derivatives thereof tocolytic oxytocin receptor antagonists
US6977254B2 (en) 2001-04-12 2005-12-20 Wyeth Hydroxy cyclohexenyl phenyl carboxamides tocolytic oxytocin receptor antagonists
US6903087B2 (en) 2001-04-12 2005-06-07 Wyeth Pyrido cyclohexenyl phenyl carboxamides tocolytic oxytocin receptor antagonists
US7326700B2 (en) 2001-04-12 2008-02-05 Wyeth Cyclohexenyl phenyl carboxamides tocolytic oxytocin receptor antagonists
EP1434763B1 (fr) * 2001-10-12 2018-01-17 Azevan Pharmaceuticals, Inc. Antagonistes v1a de vasopressine beta-lactamyl
MXPA05011521A (es) 2003-04-28 2006-01-23 Astellas Pharma Inc Derivado de 4,4-difluoro-1,2,3,4-tetrahidro-5h-1-benzazepina o una sal del mismo.
GB0406917D0 (en) 2004-03-26 2004-04-28 Photocure Asa Compounds
MX2007002248A (es) * 2004-08-25 2008-10-02 Pfizer Triazolobenzodiazepinas y su uso como antagonistas de vasopresina.
AU2006227199A1 (en) 2005-03-22 2006-09-28 Azevan Pharmaceuticals, Inc. Beta-lactamylalkanoic acids for treating premenstrual disorders
PL2356123T3 (pl) 2008-11-13 2013-03-29 Hoffmann La Roche Spiro-5,6-dihudro-4h-2,3,5,10b- tetraazabenzo[e]azuleny
EP2308866A1 (fr) 2009-10-09 2011-04-13 Bayer CropScience AG Phenylpyri(mi)dinylpyrazoles et leur utilisation comme fongicides
US8420633B2 (en) * 2010-03-31 2013-04-16 Hoffmann-La Roche Inc. Aryl-cyclohexyl-tetraazabenzo[e]azulenes
GB201005623D0 (en) 2010-04-01 2010-05-19 Vantia Ltd New polymorph
US8461151B2 (en) * 2010-04-13 2013-06-11 Hoffmann-La Roche Inc. Aryl-/heteroaryl-cyclohexenyl-tetraazabenzo[e]azulenes
US8481528B2 (en) * 2010-04-26 2013-07-09 Hoffmann-La Roche Inc. Heterobiaryl-cyclohexyl-tetraazabenzo[e]azulenes
US8513238B2 (en) * 2010-05-10 2013-08-20 Hoffmann-La Roche Inc. Heteroaryl-cyclohexyl-tetraazabenzo[E]azulenes
ES2662350T3 (es) 2010-07-01 2018-04-06 Azevan Pharmaceuticals, Inc. Procedimientos para el tratamiento del trastorno por estrés postraumático
WO2014134391A1 (fr) 2013-02-28 2014-09-04 Bristol-Myers Squibb Company Dérivés de phénylpyrazole en tant que puissants inhibiteurs de rock1 et rock2
TW201444798A (zh) 2013-02-28 2014-12-01 必治妥美雅史谷比公司 作爲強效ｒｏｃｋ１及ｒｏｃｋ２抑制劑之苯基吡唑衍生物
SI3122743T1 (sl) 2014-03-28 2023-07-31 Azevan Pharmaceuticals, Inc. Sestavki in metode za zdravljenje nevrodegenerativnih bolezni
CN111295373A (zh) 2017-09-15 2020-06-16 阿泽凡药物公司 用于治疗脑损伤的组合物和方法

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5516774A (en) * 1993-07-29 1996-05-14 American Cyanamid Company Tricyclic diazepine vasopressin antagonists and oxytocin antagonists
US5521173A (en) * 1995-01-17 1996-05-28 American Home Products Corporation Tricyclic benzazepine vasopressin antagonists
TW359669B (en) * 1995-12-15 1999-06-01 Otsuka Pharma Co Ltd Benzazepine derivatives

Also Published As

Publication number Publication date
BR9811585A (pt) 2000-09-26
PT1000062E (pt) 2004-12-31
ATE277050T1 (de) 2004-10-15
EP1000062B1 (fr) 2004-09-22
NZ502449A (en) 2002-08-28
NO20000242L (no) 2000-03-06
DE69826487D1 (de) 2004-10-28
ZA986784B (en) 2000-06-22
DK1000062T3 (da) 2004-11-22
JP4338305B2 (ja) 2009-10-07
CA2297406C (fr) 2009-02-24
RU2213094C2 (ru) 2003-09-27
CN1183134C (zh) 2005-01-05
HUP0002480A3 (en) 2002-09-30
NO315273B1 (no) 2003-08-11
TW502035B (en) 2002-09-11
KR20010022398A (ko) 2001-03-15
EP1000062A1 (fr) 2000-05-17
SI1000062T1 (en) 2004-12-31
JP2001512125A (ja) 2001-08-21
CA2297406A1 (fr) 1999-02-11
AR016557A1 (es) 2001-07-25
HUP0002480A2 (hu) 2000-11-28
WO1999006409A1 (fr) 1999-02-11
AU8663398A (en) 1999-02-22
NO20000242D0 (no) 2000-01-18
AU756959B2 (en) 2003-01-30
CN1272111A (zh) 2000-11-01
ES2229525T3 (es) 2005-04-16
DE69826487T2 (de) 2005-12-01
KR100580805B1 (ko) 2006-05-17

Similar Documents

Publication Publication Date Title
IL133788A0 (en) Tricyclic vasopressin agonists
DE69803272D1 (en) Hemmstoffe der stickstoffmonoxid-synthase
IL135248A0 (en) Novel combination
HK1003891A1 (en) Tricyclic vasopressin antagonists
PL335999A1 (en) Substituted 3-cyanoquinolines
AP2000001795A0 (en) Substituted 4-aminothiazol-2-yol
EP1002415A4 (fr) Annuaire
HK1026889A1 (en) Novel aryloxy-alkyl-dialkylamines
HUP0100587A3 (en) Padlock
PL336068A1 (en) Pharmacological agents
SI1036083T1 (en) Novel 9a-azalides
GB9704776D0 (en) Detergent - packaging combination
ZA9810184B (en) New phenyl-alkyl-imidazoles
PL341736A1 (en) Pharmacological composition
HUP0004317A3 (en) 5-ht1f agonists
IL130600A0 (en) Substituted 4-benzoyl-pyrazole
GB2323272B (en) Key holder
GB9820801D0 (en) Dual purpose stand off
IL133261A0 (en) Substituted naphthropyrans
ZA985761B (en) Substituted aryluracils
ZA986783B (en) Tricyclic pyrido vasopressin agonists.
GB9701415D0 (en) Stereoisomers
IL136525A0 (en) Agents
PL318601A1 (en) Novel 5-arylidene-4-oxo-2-imidazpglycines
GB9721984D0 (en) Dual purpose carrier